Analyst Price Targets — TTI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 12, 2026 10:48 am | Stephen Gengaro | Stifel Nicolaus | $13.00 | $9.87 | StreetInsider | TETRA Technologies Inc. (TTI) PT Raised to $13 at Stifel, 'remains a favorite name' |
| December 31, 2025 2:32 pm | — | Northland Securities | $11.50 | $9.44 | TheFly | Tetra Technologies price target raised to $11.50 from $8.50 at Northland |
| October 30, 2025 12:33 pm | Bobby Brooks | Northland Securities | $8.50 | $7.01 | TheFly | Tetra Technologies price target raised to $8.50 from $8 at Northland |
| October 15, 2025 10:53 am | Stephen Gengaro | Stifel Nicolaus | $9.00 | $7.04 | TheFly | Tetra Technologies price target raised to $9 from $6.50 at Stifel |
| September 26, 2025 1:25 pm | — | Northland Securities | $7.00 | $6.02 | TheFly | Tetra Technologies price target raised to $7 from $5.50 at Northland |
| April 15, 2025 12:25 pm | Stephen Gengaro | Stifel Nicolaus | $6.50 | $2.30 | TheFly | Tetra Technologies price target lowered to $6.50 from $7 at Stifel |
| June 14, 2022 11:15 am | Tim Moore | EF Hutton | $8.00 | $4.84 | Pulse 2.0 | TETRA Technologies (TTI) Stock Price: $8 Target And Buy Rating |
Latest News for TTI
TETRA Technologies, Inc. (TTI) Q4 2025 Earnings Call Transcript
SPRING, Texas, Feb. 25, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three and twelve months ended December 31, 2025. Fourth-Quarter 2025 Financial Highlights Revenues of $146.7 million increased 9% from the fourth quarter of 2024 Loss from continuing operations was $15.3 million, inclusive of $18.7 million of unusual charges Loss per share…
Tetra Technologies (NYSE: TTI - Get Free Report) is projected to post its Q4 2025 results after the market closes on Wednesday, February 25th. Analysts expect Tetra Technologies to post earnings of $0.03 per share and revenue of $140.9750 million for the quarter. Interested persons can find conference call details on the company's upcoming Q4 2025
San Diego, California--(Newsfile Corp. - February 2, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare pediatric diseases, today provided an update on its nephropathic cystinosis program and announced a new investigator-initiated study (IIS) collaboration with Dr. Larry…
SPRING, Texas, Feb. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) will release Fourth Quarter and Full Year 2025 results after the market close on Wednesday, February 25, 2026 and will host a conference call at 10:30 a.m. Eastern Time on Thursday, February 26, 2026.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for TTI.
U.S. House Trading
No House trades found for TTI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.